Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test sale cost 2960 AED
Fungal Candida Multiplex Detection and Differentiation RNA Detection Qualitative Test sale cost 2890 AED Fungal Candida Multiplex Detection and Differentiation RNA Detection Qualitative Test 3,400 د.إ Original price was: 3,400 د.إ.2,890 د.إCurrent price is: 2,890 د.إ.
Adenovirus and Boca Virus and Metapneumonia and RSV Detection and Differentiation RNA Detection Qualitative Test sale cost 2400 AED Adenovirus and Boca Virus and Metapneumonia and RSV Detection and Differentiation RNA Detection Qualitative Test 3,200 د.إ Original price was: 3,200 د.إ.2,400 د.إCurrent price is: 2,400 د.إ.
Sale!

Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test

Original price was: 3,290 د.إ.Current price is: 2,960 د.إ.

-10%

The “Cultured AFB Antitubercular DST Rapid 12 Drugs Panel Test” is a specialized diagnostic assessment performed to evaluate the drug susceptibility of the bacteria responsible for tuberculosis (TB), directly from cultured samples. This test plays a crucial role in identifying the most effective medication regimen for patients by testing the bacteria’s resistance against a panel of 12 different antitubercular drugs. The rapid nature of this panel ensures that results are obtained more quickly than traditional methods, facilitating timely initiation of the most appropriate treatment and improving patient outcomes.

Conducted at DNA Labs UAE, a leading facility in medical diagnostics, this test leverages advanced laboratory techniques to ensure high accuracy and reliability. With a cost of 2960 AED, the test represents a significant investment in the health and well-being of individuals suspected of having drug-resistant TB. By offering this comprehensive drug susceptibility testing, DNA Labs UAE plays a vital role in the global fight against tuberculosis, particularly in addressing the challenge of multidrug-resistant TB strains.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST RAPID 12 DRUGS PANEL Test

Test Name: CULTURED AFB ANTITUBERCULAR DST RAPID 12 DRUGS PANEL Test

Components:

  • Streptomycin
  • Isoniazid
  • Rifampicin
  • Ethambutol
  • Pyrazinamide
  • Clofazimine
  • Ethionamide
  • Capreomycin
  • Kanamycin
  • Amikacin
  • Ofloxacin
  • PAS

Price: 2960.0 AED

Sample Condition: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery: Sample Daily by 3.30 pm; Report 21 days

Method: Automated Fluorescent

Test type: Tuberculosis

Doctor: Physician

Test Department:

Pre Test Information: No special preparation required

Test Details

The CULTURED AFB ANTITUBERCULAR DST RAPID 12 DRUGS PANEL test is a laboratory test used to determine the drug susceptibility of the Mycobacterium tuberculosis complex (MTBC) bacteria. This test is performed on a culture of AFB (acid-fast bacilli) obtained from a patient’s sputum or other clinical samples. The test panel includes 12 different drugs commonly used to treat tuberculosis, including isoniazid, rifampin, ethambutol, pyrazinamide, streptomycin, kanamycin, amikacin, capreomycin, ofloxacin, moxifloxacin, levofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the MTBC bacteria.

The test is performed by exposing the AFB culture to different concentrations of each drug and observing the growth or inhibition of the bacteria. The results are interpreted as susceptible, resistant, or intermediate for each drug, indicating the effectiveness of the drug in treating the specific strain of tuberculosis. This test is important in guiding the selection of appropriate antibiotic therapy for tuberculosis patients.

Drug-resistant strains of MTBC bacteria are a growing concern, and this test helps in identifying the most effective drugs to treat the infection.

Test Name CULTURED AFB ANTITUBERCULAR DST RAPID 12 DRUGS PANEL Test
Components *Streptomycin*Isoniazid*Rifampicin *Ethambutol*Pyrazinamide *Clofazimine *Ethionamide*Capreomycin*Kanamycin *Amikacin*Ofloxacin*PAS
Price 2960.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The CULTURED AFB ANTITUBERCULAR DST RAPID 12 DRUGS PANEL test is a laboratory test used to determine the drug susceptibility of the Mycobacterium tuberculosis complex (MTBC) bacteria. This test is performed on a culture of AFB (acid-fast bacilli) obtained from a patient’s sputum or other clinical samples.

The test panel includes 12 different drugs commonly used to treat tuberculosis, including isoniazid, rifampin, ethambutol, pyrazinamide, streptomycin, kanamycin, amikacin, capreomycin, ofloxacin, moxifloxacin, levofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the MTBC bacteria.

The test is performed by exposing the AFB culture to different concentrations of each drug and observing the growth or inhibition of the bacteria. The results are interpreted as susceptible, resistant, or intermediate for each drug, indicating the effectiveness of the drug in treating the specific strain of tuberculosis.

This test is important in guiding the selection of appropriate antibiotic therapy for tuberculosis patients. Drug-resistant strains of MTBC bacteria are a growing concern, and this test helps in identifying the most effective drugs to treat the infection.

SKU: TEST-4792 Category:

Related products